Role of the eye muscles in thyroid eye disease: Identification of the principal autoantigens

Thyroid

Volumn 8, Issue 6, 1998, Pages 553-556

  Gunji, Kazuaki ^a   Kubota, Sumihara ^a   Swanson, Jil ^a   Kiljanski, Jacek ^b   Bednarczuk, Tomasz ^a,b   Wengrowicz, Sylvia ^c   Salvi, Mario ^d   Wall, Jack R ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALSEQUESTRIN; FLAVOPROTEIN; MEMBRANE PROTEIN; SUCCINATE DEHYDROGENASE;

AUTOIMMUNITY; CONFERENCE PAPER; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; GRAVES DISEASE; HASHIMOTO DISEASE; HYPERTHYROIDISM; INFLAMMATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARCOPLASMIC RETICULUM; SEQUENCE ANALYSIS;

EID: 0031835519     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.553     Document Type: Conference Paper

References (29)

1. Burch HB, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endoer Rev 14:747-793.
2. Kiljanski J, Nebes V, Wall JR 1995 The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy. Proc Intl Arch Allergy Immunol 106:204-212.
3. Weetman AP 1991 Thyroid-associated eye disease: Pathophysiology. Lancet 338:25-28.
4. Salvi M, Miller A, Wall JR 1988 Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 232:135-139.
5. Hiromatsu Y, Sato M, Tanaka K, Shoji S, Nonaka K, Chinami M, Fukazawa H 1993 Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 14:1-8.
6. Chang TC, Chang TJ, Huang YS, Hua KM, Su RJ, Kao SCS 1992 Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography. Clin Immunol Immunopathol 65:161-166.
7. Wu Y-J, Clarke SEM, Shepherd P. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid disorders. Thyroid 8:167-174.
8. Werner SC, Coleman DJ, Frazen LA 1974 Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. N Engl J Med 290:1447-1450.
9. Forrester JV, Sutherland GR, McDougall IR 1977 Dysthyroid ophthalmopathy: Orbital evaluation with β-scan ultrasonography. J Clin Endocrinol Metab 45:221-224.
10. Weetman AP, Fells P, Shine B 1989 T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy. Clin Exp Immunol 73:323-327.
11. Hufnagel TJ, Hickey WF, Cobbs NH, Jakobiec FA, Iwamo T, Eagle RC 1984 Immunohistochemical and ultrastructural studies on the external orbital tissues of a patient with Graves' disease. Ophthalmology 91:1411-1419.
12. Campbell RJ 1984 Pathology of Graves' ophthalmopathy. In: German CA, Campbell RJ, Dyer JA (eds) The Eye and Orbit in Thyroid Disease. Raven Press, New York, pp 25-32.
13. Wall JR, Bernard N, Boucher A, Salvi M, Zhang ZG, Kennerdell J, Tyutyunikov A, Genovese C 1993 Pathogenesis of thyroid-associated ophthalmopathy: An autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis. Clin Immunol Immunopathol 68:1-8.
14. Gunji K, Kubota S, Stolarski, C, Wall JR 1997 Cloning and characterization of a novel thyroid and eye muscle shared autoantigen associated with the development of ophthalmopathy in patients with thyroid autoimmunity (abstract). Proc 70th Annual Meeting of the American Thyroid Association, Colorado Springs, October, 1997.
15. Gunji K, Kubota S, Stolarski C, J Wall JR 1998 Sequencing and cloning of a 64 kDa calcium binding muscle protein which is identified as calsequestrin: Prevalence of serum autoantibodies in patients with thyroid-associated ophthalmopathy. Autoimmunity (in press).
16. Kubota S, Gunji K, Ackrell BAC, Cochran B, Stolarski C, Wengrowicz S, Hiromatsu Y, Kennerdell JS, Wall JR 1998 The 64 kDa eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab 83:443-447.
17. Dong Q, Ludgate M, Vassart G 1991 Cloning and sequenc-ing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 72:1375-1381.
18. Zhang ZG, Wall Jr, Bernard NF 1996 Tissue distribution and quantitation of a gene expressing a 64 kDa antigen associated with thyroid-associated orbitopathy. Clin Immunol Immunopathol 80:236-244.
19. Zhang ZG, Wall JR, Bernard NF 1995 Identification of antigenie epitopes of ID antigen recognized by antibodies in the serum of patients with thyroid-associated ophthalmopathy. Clin Immunol Immunopathol 77:193-200.
20. 1D, a recombinant 64 kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity. Clin Immunol Immunopathol 70:225-233.
21. Kromminga A, Hagel C, Arndt R, Schuppen F 1998 Graves' patients suffering from thyroid-associated ophthalmopathy (TAO) are positive for autoantibodies against ID protein which is expressed in human thyroid and eye muscle tissue. J Clin Endocrinol Metab (in press).
22. Morris A, Farnsworth L, Ackrell BAC, Turnbull DM, Birch Machin MA 1994 The cDNA sequence of the flavoprotein subunit of human heart succinate dehydrogenase. Biochim Biophys Acta 1185:125-128.
23. Kita K, Oya H, Gennis RB, Ackrell BA, Kasahara M 1990 Human complex II (succinate-ubiquinone oxidireductase): cDNA cloning of iron sulfur (Ip) subunit of liver mitochondria Biochem Biophys Res Commun 166:1091-108.
24. Hiromatsu Y, Cadarso L, Salvi M, Wall JR 1990 Significance of cytotoxic eye muscle antibodies in patients with thyroidassociated ophthalmopathy. Autoimmunity 5:205-213.
25. Zhang Z-G, Medeiros-Neto G, lacona A, Lima N, Hiromatsu Y, Salvi M, Triller H, Bernard N, Wall JR 1989 Studies of cytotoxic antibodies against eye muscle antigens in patients with thyroid-associated ophthalmopathy. Acta Endocrinologica (Copenh) 2(SuppI 2):23-30.
26. Barsouk A, Wengrowitz S, Scalise D, Stolarski C, Nebes V, Sato M, Wall JR 1995 New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirms their importance in thyroid-associated ophthalmopathy. Thyroid 5:195-200.
27. Salvi M, Scalise D, Stolarski C, Arthurs B, Lindley S, Kennerdell J, Wall JR 1995 Upper eyelid retraction in the absence of other evidence for progressive ophthalmopathy is associated with eye muscle autoantibodies. Clin Immunol Immunopathol 74:44-50.
28. Rootman J, Patel S, Berry K, Nugent R 1987 Pathological and clinical study of Muller's muscle in Graves' ophthalmopathy. Can J Ophthalmology 22:32-36.
29. Barsouk A, Kiljanski J Stolarski CS, Nebes V, Peele K, Kennerdell JS, Wall JR 1998 Antibodies against Muller's muscle in patients with eyelid lag and retraction associated or not with progressive ophthalmopathy. J Endocrinol Invest (in press).